P2RY12 and hyperlipidemia: The routinely used animal models do not adequately mimic the clinical scenario of MI/R injury in patients with co-morbidities and co-medications, such as aging, hyperglycemia, hypertension, hyperlipidemia, and the use of P2Y12 antagonists [3].